This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
CENRIFKI is indicated for the treatment of nrSPMS and to slow disability accumulation independent of relapses in adults
Diabetes
Dermatology
Cardiology
Vaccines
Rare Disease
Neurology
Rare Blood Disorders
Respiratory
Oncology
Rhinology
Allergic Fungal Rhinosinusitis
Other topics
Transplant
Gastroenterology
Hematology
.2025-06-04-15-42-22.png)
.2025-06-09-10-15-30.png)
.2025-06-24-14-49-57.png)
.2025-08-18-13-29-17.png)
.2025-10-08-09-26-02.svg){kind=logo}
